SAB Biotherapeutics, Inc. Warrant — Institutional Ownership

Which tracked institutions hold SABSW, and how they changed the position last quarter. Latest holdings as of Jun 30, 2026. Source: SEC 13-F filings.

16
Funds holding
$21192908
Total value held
Buying
14 added/new · 2 reduced
# Institution Value Shares Δ Shares Change (QoQ)
1 Blackrock, Inc. $11957462 3066016 +2764690 +917.51%
2 Ameriprise Financial Inc $2382975 611019 +611019 NEW BUY
3 State Street Corp $2070241 530831 +456600 +615.11%
4 Ubs Group Ag $1427009 372445 +372445 NEW BUY
5 Northern Trust Corp $1413707 362489 +305063 +531.23%
6 Goldman Sachs Group Inc $746089 191305 +77365 +67.90%
7 Bank Of New York Mellon Corp $420604 107847 +107847 NEW BUY
8 Wells Fargo & Company/Mn $171924 44083 +44083 NEW BUY
9 Barclays Plc $140019 35902 +35406 +7138.31%
10 Citigroup Inc $103677 26584 -3390 -11.31%
11 Bank Of America Corp /De/ $97991 25126 -30571 -54.89%
12 Invesco Ltd. $88112 22593 +22593 NEW BUY
13 Jpmorgan Chase & Co $70547 18089 +18002 +20691.95%
14 Morgan Stanley $55498 160189 +1839 +1.16%
15 Pnc Financial Services Group, Inc. $40053 10270 +2570 +33.38%
16 Royal Bank Of Canada $7000 1687 +1686 +168600.00%

Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.